Skip to main content
CDC Website

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

The landscape of treatment for hepatitis C virus (HCV) infection has evolved substantially since the introduction of highly effective HCV protease inhibitor therapies in 2011. The pace of change has increased rapidly as numerous new drugs with different mechanisms of action have become available over the past few years. To provide healthcare professionals with timely guidance as new therapies become available and are integrated into HCV regimens, the Infectious Diseases Society of America (IDSA) and American Association for the Study of Liver Diseases (AASLD), developed a web-based process for the rapid formulation and dissemination of evidence-based, expert-developed recommendations for hepatitis C management.

Audiences:
Health Professionals
Author:
American Association for the Study of Liver Diseases and the Infectious Disease Society of America
Focus Area:
Viral Hepatitis
Subjects:
Hepatitis C
Publication Date:
2021
Format:
Report
Last Updated Date:
Publication ID:
365761